Lack of association between Rh status, Rh immune globulin in pregnancy and autism

American Journal of Medical Genetics, Part A

Volumn 143, Issue 13, 2007, Pages 1397-1407

  Miles, Judith H ^a   Takahashi, T Nicole ^a  

^a University of Missouri   (United States)

Author keywords

Autism; Rh; Rh immune globulin; Rhogam; Thimerosal

Indexed keywords

DRUG PRESERVATIVE; ETHYLMERCURIC CHLORIDE; RHESUS D ANTIBODY; THIOMERSAL;

AGE; ARTICLE; ASPERGER SYNDROME; AUTISM; BLOOD GROUP RHESUS SYSTEM; DEMOGRAPHY; ETHNICITY; GENDER; HEAD CIRCUMFERENCE; HUMAN; INTELLIGENCE QUOTIENT; INTERVIEW; PHENOTYPE; PREGNANCY; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; RHESUS INCOMPATIBILITY; SOCIOECONOMICS; STATISTICAL ANALYSIS; TERATOLOGY; UNITED STATES;

ADULT; AUTISTIC DISORDER; CHILD; FEMALE; HUMANS; MALE; PREGNANCY; PRESERVATIVES, PHARMACEUTICAL; PREVALENCE; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN; THIMEROSAL;

EID: 34447331942     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.31846     Document Type: Article

References (88)

1. Aase JM. 1990. Diagnostic Dysmorphology. New York: Plenum Press.
2. American Academy of Pediatrics. 2003. Report of the Committee on Infectious Diseases. In: Pickering LK, editor. Red Book, 26th edition. Elk Grove Village, IL: American Academy of Pediatrics.
3. American College of Obstetricians, Gynecologists (ACOG). 1999. Prevention of Rh D alloimmunization. Washington (DC): American College of Obstetricians and Gynecologists (ACOG).
4. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association.
5. American Red Cross Web Site. Available from http://www. givelife.org. Accessed May 3, 2006.
6. Arndt TL, Stodgell CJ, Rodier PM. 2005. The teratology of autism. Int J Dev Neurosci 23:189-199.
7. Arvidsson T, Danielsson B, Forsberg P, Gillberg C, Johansson M, Kjellgren G. 1997. Autism in 3-6-year-old children in a suburb of Goteborg, Sweden. Autism 1:163-173.
8. Asperger H. 1944. Die Autistischen Psychopathen in Kindersalter. Cambridge: Cambridge University Press.
9. Baird G, Charman T, Baron-Cohen S, Cox A, Swettenham J, Wheelwright S, Drew A. 2000. A screening instrument for autism at 18 months of age: A 6-year follow-up study. J Am Acad Child Adolesc Psychiatry 39:694-702.
10. Ball LK, Ball R, Pratt RD. 2001. An assessment of thimerosal use in childhood vaccines. Pediatrics 107:1147-1154.
11. Bernard S, Enayati A, Redwood L, Roger H, Binstock T. 2001. Autism: A novel form of mercury poisoning. Med Hypotheses 56:462-471.
12. Bernard S, Enayati A, Roger H, Binstock T, Redwood L. 2002. The role of mercury in the pathogenesis of autism. Mol Psychiatry 7:S42-S43.
13. Bowman J. 2003. Thirty-five years of Rh prophylaxis. Transfusion 43:1661-1666.
14. Brecher ME. editors. 2005. Technical Manual, 15th edition. Bethesda, Maryland: AABB.
15. Centers for Disease Control and Prevention. 1999. Notice to readers: Thimerosal in vaccines: A joint statement of the American Academy of Pediatrics and the Public Health Service. Morb Mort Wkly Rep 48:563-565.
16. Centers for Disease Control and Prevention. 2006. Mental health in the United States: Parental report of diagnosed autism in children aged 4-17 years - United States, 2003-2004. Morb Mort Wkly Rep 55:481-486.
17. Chakrabarti S, Fombonne E. 2001. Pervasive developmental disorders in preschool children. JAMA 285:3093-3099.
18. Chakrabarti S, Fombonne E. 2005. Pervasive developmental disorders in preschool children: Confirmation of high prevalence. Am J Psychiatry 162:1133-1141.
19. Clarke C, Hussey RM. 1994. Decline in deaths from rhesus haemolytic disease of the newborn. J R Coll Physicians Lond 28:310-311.
20. DeWilde S, Carey IM, Richards N, Hilton SR, Cook DG. 2001. Do children who become autistic consult more often after MMR vaccination? Br J Gen Pract 51:226-227.
21. Egger G, Liang G, Aparicio A, Jones PA. 2004. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429:457-463.
22. Fombonne E. 2001. Is there an epidemic of autism? Pediatrics 107:411-412.
23. Fombonne E. 2003. Modern views of autism. Can J Psychiatry 48:503-505.
24. Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D. 2006. Pervasive developmental disorders in Montreal, Quebec, Canada: Prevalence and links with immunizations. Pediatrics 118:e139-e150.
25. Fries AB, Ziegler TE, Kurian JR, Jacoris S, Pollak SD. 2005. Early experience in humans is associated with changes in neuropeptides critical for regulating social behavior. Proc Natl Acad Sci USA 102:17237-17240.
26. Geier DA, Geier MR. 2005. A two-phased population epidemiological study of the safety of thimerosal-containing vaccines: A follow-up analysis. Med Sci Monit 11:CR160-CR170.
27. Gillberg C. 1998. Chromosomal disorders and autism. J Autism Dev Disord 28:415-425.
28. Hall JG, Froster-Iskenius UG, Allanson JE. 1989. Handbook of Normal Physical Measurements. New York: Oxford University Press.
29. Harada M. 1995. Minamata disease: Methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol 25:1-24.
30. Hollingshead AB. 1975. Four Factor Index of Social Status. New Haven, CT: Department of Sociology, Yale University.
31. Holmes AS, Blaxill MF, Haley BE. 2003. Reduced levels of mercury in first baby haircuts of autistic children. Int J Toxicol 22:277-285.
32. Honda H, Shimizu Y, Misumi K, Niimi M, Ohashi Y. 1996. Cumulative incidence and prevalence of childhood autism in children in Japan. Br J Psychiatry 169:228-235.
33. Honda H, Shimizu Y, Rutter M. 2005. No effect of MMR withdrawal on the incidence of autism: A total population study. J Child Psychol Psychiatry 46:572-579.
34. Hong EJ, West AE, Greenberg ME. 2005. Transcriptional control of cognitive development. Curr Opin Neurobiol 15: 21-28.
35. Hornig M, Chian D, Lipkin WI. 2004. Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol Psychiatry 9:833-845.
36. Howard H, Martlew V, McFadyen I, Clarke C, Duguid J, Bromilow I, Eggington J. 1998. Consequences for fetus and neonate of maternal red cell allo-immunisation. Arch Dis Child Fetal Neonatal Ed 78:F62-F66.
37. Hviid A, Stellfeld M, Wohlfahrt J, Melbye M. 2003. Association between thimerosal-containing vaccine and autism. JAMA 290:1763-1766.
38. Insel BJ, Brown AS, Bresnahan MA, Schaefer CA, Susser ES. 2005. Maternal-fetal blood incompatibility and the risk of schizophrenia in offspring. Schizophr Res 80:331-342.
39. Institute of Medicine. 2001. MMR vaccine and thimerosal-containing vaccines are not associated with autism, IOM report says. IOM 5-18-2004.
40. Institute of Medicine Immunization Safety Review Committee. 2001. Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism. Washington, DC: National Academy Press.
41. Jaenisch R, Bird A. 2003. Epigenetic regulation of gene expression: How the genome integrates intrinsic and environmental signals. Nat Genet 33:245-254.
42. Jick H, Kaye JA. 2003. Epidemiology and possible causes of autism. Pharmacotherapy 23:1524-1530.
43. Jick H, Kaye J. 2004. Autism and DPT Vaccination in the United Kingdom. New Engl J Med 350:2722-2723.
44. Jones KL. 1997. Smith's Recognizable Patterns of Human Malformation. Philadelphia: WB Saunders Company.
45. Jorde LB, Mason-Brothers A, Waldmann R, Ritvo ER, Freeman BJ, Pingree C, McMahon WM, Petersen B, Jenson WR, Mo A. 1990. The UCLA-University of Utah epidemiologic survey of autism: Genealogical analysis of familial aggregation. Am J Hum Genet 36:85-88.
46. Kanner L. 1943. Autistic disturbances of affective contact. Nervous Child 2:217-250.
47. Kaye JA, Mar Melero-Montes M, Jick H. 2001. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: A time trend analysis. BMJ 322:460-463.
48. Keller F, Persico AM. 2003. The neurobiological context of autism. Mol Neurobiol 28:1-22.
49. Kennedy RFJ. Deadly Immunity. Rolling Stone 6-20-2005.
50. Klin A. 2003. Asperger syndrome: An update. Rev Bras Psiquiatr 25:103-109.
51. Kraft P, Palmer CG, Woodward AJ, Turunen JA, Minassian S, Paunio T, Lonnqvist J, Peltonen L, Sinsheimer JS. 2004. RHD maternal-fetal genotype incompatibility and schizophrenia: Extending the MFG test to include multiple siblings and birth order. Eur J Hum Genet 12:192-198.
52. Lord C, Rutter M, Le Couteur A. 1994. Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders. J Autism Dev Disord 24:659-685.
53. Luyster R, Richler J, Risi S, Hsu WL, Dawson G, Bernier R, Dunn M, Hepburn S, Hyman SL, McMahon WM, Goudie-Nice J, Minshew N, Rogers S, Sigman M, Spence MA, Goldberg WA, Tager-Flusberg H, Volkmar FR, Lord C. 2005. Early regression in social communication in autism spectrum disorders: A CPEA Study. Dev Neuropsychol 27:311-336.
54. Madsen KM, Hviid A, Vestergaard M, Schendel D, Wohlfahrt J, Thorsen P, Olsen J, Melbye M. 2002. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 347:1477-1482.
55. Mercer L, Creighton S, Holden JJ, Lewis ME. 2006. Parental perspectives on the causes of an autism spectrum disorder in their children. J Genet Couns 15:41-50.
56. Miles JH, Hillman RE. 2000. Value of a clinical morphology examination in autism. Am J Med Genet 91:245-253.
57. Miles JH, McCathren R. 2005. Autism, GeneTests: Medical genetics information resource. Seattle: University of Washington. Available from http://genetreviews.org/.
58. Miles JH, Hadden L, Takahashi TN, Hillman RE. 2000. Head circumference is an independent clinical finding associated with autism. Am J Med Genet 95:339-350.
59. Miles JH, Takahashi TN, Hillman RE, Martin KL. 2004. Autism symptoms are less severe in girls with essential autism [Abstract 120]. Presented at the annual meeting of The American Society of Human Genetics, October 28, 2004, Toronto, Canada. Available from http://www.ashg.org/ genetics/ashg04s/index. shtml.
60. Miles JH, Takahashi TN, Bagby S, Sahota PK, Vaslow DF, Wang CH, Hillman RE, Farmer JE. 2005. Essential versus complex autism: Definition of fundamental prognostic subtypes. Am J Med Genet Part A 135A:171-180.
61. Mollison PL, Engelfriet DP, Contreras M. 1993. Blood Transfusion in Clinical Medicine, 9th edition. London: Oxford, Blackwell Scientific Publications.
62. Muhle R, Trentacoste SV, Rapin I. 2004. The genetics of autism. Pediatrics 113:e472-e486.
63. Nelson KB, Bauman ML. 2003. Thimerosal and autism? Pediatrics 111:674-679.
64. Palmer CG, Turunen JA, Sinsheimer JS, Minassian S, Paunio T, Lonnqvist J, Peltonen L, Woodward JA. 2002. RHD maternal-fetal genotype incompatibility increases schizophrenia susceptibility. Am J Hum Genet 71:1312-1319.
65. Parker SK, Schwartz B, Todd J, Pickering LK. 2004. Thimerosal-containing vaccines and autistic spectrum disorder: A critical review of published original data. Pediatrics 114:793-804.
66. Peltola H, Patja A, Leinikki P, Valle M, Davidkin I, Paunio M. 1998. No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet 351:1327-1328.
67. Petrides M, Stack G. 2001. Practical Guide to Transfusion Medicine. Bethesda, Maryland: AABB Press.
68. Pichichero ME, Cernichiari E, Lopreiato J, Treanor J. 2002. Mercury concentrations and metabolism in infants receiving vaccines containing thiomersal: A descriptive study. Lancet 360:1737-1741.
69. Rimland B. 2004. Association between thimerosal-containing vaccine and autism. JAMA 291:180-181.
70. Rodenhiser D, Mann M. 2006. Epigenetics and human disease: Translating basic biology into clinical applications. CMAJ 174:341-348.
71. Roid GH. 1997. Leiter International Performance Scale-Revised: Examiners Manual. Wood Dale, IL: Stoelting.
72. Royal College of Physicians. Consensus statement from the Royal College of Physicians of Edinburgh/Royal College of Obstetricans and Gynecologists Consensus Conference on Anti-D Prophylaxis. 1997. Transfus Med 7:143-144.
73. Rutter M. 2005. Incidence of autism spectrum disorders: Changes over time and their meaning. Acta Paediatr 94:2-15.
74. Singh SM, McDonald P, Murphy B, O'Reilly R. 2004. Incidental neurodevelopmental episodes in the etiology of schizophrenia: An expanded model involving epigenetics and development. Clin Genet 65:435-440.
75. Sparrow S, Balla D, Cicchetti D. 1984. Vineland Adaptive Behavior Scales. Circle Pines, MN: American Guidance Service.
76. Stoelb M, Yarnal R, Miles JH, Takahashi TN, Farmer J, McCathren R. 2004. Predicting responsiveness to treatment of children with autism: The importance of physical dysmorphology. Focus Autism Other Dev Disabl 19:66-77.
77. Szyf M, Weaver IC, Champagne FA, Diorio J, Meaney MJ. 2005. Maternal programming of steroid receptor expression and phenotype through DNA methylation in the rat. Front Neuroendocrinol 26:139-162.
78. Thorndike RL, Hagen EP, Sattler JM. 1986. Stanford-Binet Intelligence Scale. Riverside, CA: Riverside.
79. Ulm B, Svolba G, Ulm MR, Bernaschek G, Panzer S. 1999. Male fetuses are particularly affected by maternal alloimmunization to D antigen. Transfusion 39:169-173.
80. USDA Food and Drug Administration, Department of Health and Human Services. 2004. Mercury in plasma-derived products. Available at http://www.fda.gov/cber/blood/mercplasma. htm. Accessed May 22, 2006.
81. Wakefield AJ. 1999. MMR vaccination and autism. Lancet 354: 949-950.
82. Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA. 1998. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children [see comments]. Lancet 351:637-641.
83. Waterland RA, Jirtle RL. 2004. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 20:63-68.
84. Weaver IC, Cervoni N, Champagne FA, D'Alessio AC. Sharma S, Seckl JR, Dymov S, Szyf M, Meaney MJ. 2004. Epigenetic programming by maternal behavior. Nat Neurosci 7:847-854.
85. Weaver IC, Champagne FA, Brown SE, Dymov S, Sharma S, Meaney MJ, Szyf M. 2005. Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: Altering epigenetic marking later in life. J Neurosci 25:11045-11054.
86. Wechsler D. 1991. Manual for the Wechsler Scale for Children. San Antonio, TX: Psychological Corp.
87. Werner E, Dawson G. 2005. Validation of the phenomenon of autistic regression using home videotapes. Arch Gen Psychiatry 62:889-895.
88. Zandi PP, Kalaydjian A, Avramopoulos D, Shao H, Fallin MD, Newschaffer DH. 2006. Rh and ABO maternal-fetal incompatibility and risk of autism. Am J Med Genet Part B Neuropsychiatr Genet 141B:643-647.